[1] 刘志民,刘子毓.代谢综合征研究现状及展望[J].中华老年心脑血管病杂志,2015,17(4):337-338. [2] Saklayen MG.The global epidemic of the metabolic syndrome[J]. Curr Hypertens Rep, 2018, 20(2): 12. [3] Aguilar M, Bhuket T, Torres S, et al.Prevalence of the metabolic syndrome in the United States, 2003-2012[J]. JAMA, 2015, 313(19): 1973-1974. [4] Ansarimoghaddam A, Adineh HA, Zareban I, et al.Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies[J]. Diabetes Metab Syndr, 2018, 12(2): 195-201. [5] Raposo L, Severo M, Barros H, et al.The prevalence of the metabolic syndrome in Portugal: the PORMETS study[J]. BMC Public Health, 2017, 17(1): 555. [6] 吴民松, 周福, 尹朝兰. 昭通市城镇居民代谢综合征患病率及危险因素分析[J]. 大理大学学报, 2019, 4(10): 88-91. [7] 庄丽燕, 李静, 朱慧英, 等. 上海某郊区成年居民脂肪肝和代谢综合征的患病情况及影响因素分析[J]. 上海预防医学, 2019, 31(6): 473-478. [8] 李改仙. 代谢综合征流行特征及其影响因素研究[J]. 国际感染病学(电子版), 2019, 8(1): 20-22. [9] Alberti KG, Eckel RH, Grundy SM, et al.Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the study of obesity[J]. Circulation, 2009, 120(16): 1640-1645. [10] Kachur S, Morera R, De Schutter A, et al.Cardiovascular risk in patients with prehypertension and the metabolic syndrome[J]. Curr Hypertens Rep, 2018, 20(2): 15. [11] Younis A, Younis A, Tzur B, et al.Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease[J]. Cardiovasc Diabetol, 2016, 15(1): 149. [12] Chen Q, Zhang Y, Ding D, et al.Metabolic syndrome and its individual components with mortality among patients with coronary heart disease[J]. Int J Cardiol, 2016, 224: 8-14. [13] Arbel Y, Havakuk O, Halkin A, et al.Relation of metabolic syndrome with long-term mortality in acute and stable coronary disease[J]. Am J Cardiol, 2015, 115(3): 283-287. [14] Lu J, Wang L, Li M, et al.Metabolic syndrome among adults in China: The 2010 China noncommunicable disease surveillance[J]. J Clin Endocrinol Metab, 2017, 102(2): 507-515. [15] Li Y, Zhao L, Yu D, et al.Metabolic syndrome prevalence and its risk factors among adults in China: A nationally representative cross-sectional study[J]. PLoS One, 2018, 13(6): e199293. [16] 丁贤彬,毛德强,沈卓之,等.重庆市城市居民代谢综合征患病率及影响因素分析[J]. 华南预防医学, 2017, 43(4): 301-305. [17] 许燕君,许晓君,刘涛,等.广东省就业流动人口代谢综合征患病率及影响因素研究[J]. 华南预防医学, 2016, 42(6): 501-509. [18] 符芳敏, 王会宽, 马涛, 等. 琼海市居民主要慢性病及代谢综合征调查[J]. 中国热带医学, 2018, 18(1): 37-40. [19] 杨巧媛, 蒋义国, 刘世明. 广州城区成年人代谢综合征相关危险因素调查[J]. 实用预防医学, 2009, 16(4): 1076-1077. [20] 郭海健, 念馨,梁友芳, 等. 基于多中心横断面调查的中国人群代谢综合征的流行情况及危险因素[J]. 中华疾病控制杂志, 2019, 23(7): 796-801. [21] 孙香云, 刘学双, 张海滨, 等. 吸烟对代谢综合征的影响[J]. 职业与健康, 2012, 28(7): 846-847. [22] 陈霞. 代谢综合征与吸烟[J]. 中外医学研究, 2011, 9(18): 152. |